Induction of sensitivity to activation-induced death in primary CD4(+) cells: A role for interleukin-2 in the negative regulation of responses by mature CD4(+) T cells

被引:47
作者
Wang, RD [1 ]
Rogers, AM [1 ]
Rush, BJ [1 ]
Russell, JH [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MOL BIOL & PHARMACOL,ST LOUIS,MO 63110
关键词
interleukin-2; activation-induced death; CD95; lymphocyte regulation;
D O I
10.1002/eji.1830260944
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examine the requirements for converting naive, mature CD4(+) cells from an activation-induced death (AID)-resistant to a -sensitive phenotype. Priming for sensitivity to AID can be divided into two steps. The first is a mitogen/CD3-dependent, cyclosporin-sensitive signal and the second a cytokine-dependent, cyclosporin-insensitive one. Under these conditions, interleukin (IL)-2, but not IL-4, IL-7 or IL-15, the receptors of which share a common receptor gamma chain, is capable of providing the cytokine signal for inducing sensitivity to AID. Increased expression of the low-affinity IL-2R alpha chain (CD25) is associated with acquisition of AID sensitivity and antibodies to CD25 block acquisition of AID sensitivity in the presence of IL-2. As with T cell hybridomas, AID is dependent on both CD95 and CD95 ligand (CD95L) expression, but unlike hybridomas, the sensitive and resistant phenotypes of primary CD4(+) cells cannot be distinguished by levels of CD95 expression, functional CD95L nor the fraction of cells in cycle. The results suggest that the unique function of IL-2 is to regulate proteins, either not important or constitutively regulated in T cell hybridomas, that are essential for cell-autonomous suicide of activated CD4(+) cells. These experiments provide a mechanism for the recent observations of chronic lymphoproliferation and autoimmune disease in mice with null mutations in IL-2 or CD25.
引用
收藏
页码:2263 / 2270
页数:8
相关论文
共 56 条
  • [1] ABRAMS SI, 1991, J IMMUNOL, V146, P405
  • [2] T-CELL RECEPTOR-INDUCED FAS LIGAND EXPRESSION IN CYTOTOXIC T-LYMPHOCYTE CLONES IS BLOCKED BY PROTEIN-TYROSINE KINASE INHIBITORS AND CYCLOSPORINE-A
    ANEL, A
    BUFERNE, M
    BOYER, C
    SCHMITTVERHULST, AM
    GOLSTEIN, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2469 - 2476
  • [3] T-CELL TUMOR ELIMINATION AS A RESULT OF T-CELL RECEPTOR MEDIATED ACTIVATION
    ASHWELL, JD
    LONGO, DL
    BRIDGES, SH
    [J]. SCIENCE, 1987, 237 (4810) : 61 - 64
  • [4] PROPRIOCIDAL APOPTOSIS OF MATURE T-LYMPHOCYTES OCCURS AT S-PHASE OF THE CELL-CYCLE
    BOEHME, SA
    LENARDO, MJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) : 1552 - 1560
  • [5] GROWTH-FACTORS CAN ENHANCE LYMPHOCYTE SURVIVAL WITHOUT COMMITTING THE CELL TO UNDERGO CELL-DIVISION
    BOISE, LH
    MINN, AJ
    JUNE, CH
    LINDSTEN, T
    THOMPSON, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5491 - 5495
  • [6] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [7] Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth
    Chastagner, P
    Moreau, JL
    Jacques, Y
    Miyasaka, M
    Kondo, M
    Sugamura, K
    Theze, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) : 201 - 206
  • [8] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [9] A FAS-ASSOCIATED PROTEIN FACTOR, FAF1, POTENTIATES FAS-MEDIATED APOPTOSIS
    CHU, KT
    NIU, XH
    WILLIAMS, LT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) : 11894 - 11898
  • [10] PARAMETERS CONTROLLING THE PROGRAMMED DEATH OF MATURE MOUSE T-LYMPHOCYTES IN HIGH-DOSE SUPPRESSION
    CRITCHFIELD, JM
    ZUNIGAPFLUCKER, JC
    LENARDO, MJ
    [J]. CELLULAR IMMUNOLOGY, 1995, 160 (01) : 71 - 78